Accordingly, low expression of E-cadherin in OSCC has been associated with clinical and histopathological features of malignancy, such as metastasis, recurrence, low survival and poor tumor differentiation (11-13), and it has been referred to by some authors as a “high-risk marker of malignancy” (14,15). This evidence concerns the gene CDH1 and neoplasm.